Kuliczkowski K, Sciborski R, Kuliszkiewicz-Janus M, Gałazka Z
Katedry i Kliniki Hematologii Ak. Med., Wrocławiu.
Wiad Lek. 1990;43(5-6):188-92.
Brown Livex, a preparation of animal blood in doses of 5.0 g twice daily was given to 33 patients with proliferative diseases of bone marrow and lymphatic system during and after treatment with cytostatic agents. The course of treatment was 3 months. The effect of the preparation was studied on the wellbeing of the patients, body weight, general fitness (Karnofsky scale) and the levels of haemoglobin, haematocrit and beta-lipoproteins. The control groups comprised 20 patients with similar diseases and similar cytostatic treatment. In the studied group a positive effect was observed of the preparation on weight gain (26 out of 33 patients), well-being (24 of 33) and general fitness (17 of 33). In the control group during the same-time of observation weight loss was noted in 11 of 20 cases, well-being deterioration in 7 of 20, and decreased general fitness in 7 of 20. Livex treatment had no effect on haemoglobin level, haematocrit value, total serum protein, albumins and beta-lipoproteins.
在对33例骨髓和淋巴系统增殖性疾病患者进行细胞抑制剂治疗期间及治疗后,给予Brown Livex(一种动物血液制剂),剂量为每日两次,每次5.0克。治疗疗程为3个月。研究了该制剂对患者健康状况、体重、总体健康状况(卡氏评分)以及血红蛋白、血细胞比容和β-脂蛋白水平的影响。对照组包括20例患有相似疾病并接受相似细胞抑制剂治疗的患者。在研究组中,观察到该制剂对体重增加(33例患者中的26例)、健康状况(33例中的24例)和总体健康状况(33例中的17例)有积极作用。在对照组观察的同一时期,20例中有11例体重减轻,20例中有7例健康状况恶化,20例中有7例总体健康状况下降。Livex治疗对血红蛋白水平、血细胞比容值、血清总蛋白、白蛋白和β-脂蛋白没有影响。